Taysha Gene Therapies (TSHA) Non-cash Items (2019 - 2026)

Taysha Gene Therapies has disclosed Non-cash Items across 8 years of filings, most recently posting $200000.0 for Q1 2026.

• Non-cash Items for Q1 2026 came in at $200000.0, down 99.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $200000.0 (down 99.1% YoY), and the FY2025 annual result was $81.7 million, up 4052.36% from the prior year.
• Non-cash Items came in at $200000.0 for Q1 2026 at Taysha Gene Therapies, down from $81.7 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $81.7 million in Q4 2025 to a low of $62000.0 in Q4 2022.
• The 5-year median for Non-cash Items is $6.9 million (2024), against an average of $14.1 million.
• Peak annual rise in Non-cash Items reached 22153.52% in 2022, while the deepest fall reached 99.86% in 2022.
• Taysha Gene Therapies' Non-cash Items stood at $62000.0 in 2022, then jumped by 3061.29% to $2.0 million in 2023, then increased by 0.36% to $2.0 million in 2024, then surged by 4052.36% to $81.7 million in 2025, then sank by 99.76% to $200000.0 in 2026.
• The last three Non-cash Items figures came in at $200000.0 (Q1 2026), $81.7 million (Q4 2025), and $300000.0 (Q3 2025), per Business Quant data.